
Natera NTRA
$ 198.76
-1.07%
Quarterly report 2024-Q3
added 11-12-2024
Natera EBITDA per Share 2011-2026 | NTRA
Annual EBITDA per Share Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.33 | -5.05 | -2.56 | -1.77 | -1.85 | -2.38 | -1.75 | -2.07 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.75 | -5.33 | -2.85 |
Quarterly EBITDA per Share Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -1.4 | - | -1.62 | -1.31 | -0.7 | - | -0.61 | -0.6 | -0.42 | - | -0.22 | -0.36 | -0.47 | - | -0.36 | -0.43 | -0.53 | - | -0.38 | -0.47 | -0.62 | - | -0.43 | -0.39 | -0.17 | - | -0.36 | -2.27 | -0.88 | - | 1.74 | 0.23 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.74 | -2.27 | -0.543 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
5.49 | $ 115.75 | 0.6 % | $ 35.2 B | ||
|
Celcuity
CELC
|
-3.68 | $ 135.21 | 0.71 % | $ 6.32 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 8.35 | -8.34 % | $ 11.1 M | ||
|
Castle Biosciences
CSTL
|
-0.07 | $ 21.3 | 8.18 % | $ 617 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
-2.18 | $ 17.49 | -1.02 % | $ 538 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 21.66 | 0.56 % | $ 1.15 B | ||
|
Guardant Health
GH
|
-3.17 | $ 123.99 | 3.45 % | $ 15.5 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 117.11 | 2.86 % | $ 9.66 B | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 1.8 | - | $ 7.96 M | ||
|
Illumina
ILMN
|
-3.01 | $ 144.44 | -0.54 % | $ 23 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 99.8 | -0.26 % | $ 6.74 B | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 162.31 | 3.68 % | $ 8.04 B | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 100.16 | -0.11 % | $ 22.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
-0.62 | $ 9.52 | 2.64 % | $ 1.22 B | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 431.23 | 0.49 % | $ 12.4 B | ||
|
National Research Corporation
NRC
|
1.35 | $ 19.11 | 0.37 % | $ 428 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 3.9 | 1.17 % | $ 361 M | ||
|
Personalis
PSNL
|
-0.87 | $ 8.99 | 0.62 % | $ 802 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.71 | -0.91 % | $ 25.3 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 6.38 | -0.78 % | $ 266 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.38 | -3.73 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 65.08 | 0.32 % | $ 3.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 260.07 | 0.64 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 448.9 | 0.15 % | $ 169 B | ||
|
Waters Corporation
WAT
|
6.02 | $ 342.16 | 1.03 % | $ 20.4 B | ||
|
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.64 | -0.94 % | $ 230 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.32 | 1.91 % | $ 2.02 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 194.7 | 0.93 % | $ 21.6 B |